Alitto, Anna Rita
 Distribuzione geografica
Continente #
NA - Nord America 600
EU - Europa 501
AS - Asia 151
AF - Africa 3
SA - Sud America 2
Continente sconosciuto - Info sul continente non disponibili 1
Totale 1.258
Nazione #
US - Stati Uniti d'America 593
DE - Germania 147
SE - Svezia 119
CN - Cina 73
UA - Ucraina 61
IT - Italia 54
IN - India 34
IE - Irlanda 31
SG - Singapore 31
FR - Francia 28
GB - Regno Unito 16
RU - Federazione Russa 11
BE - Belgio 8
BZ - Belize 7
CZ - Repubblica Ceca 6
FI - Finlandia 6
IR - Iran 5
PL - Polonia 5
TR - Turchia 4
CH - Svizzera 3
CI - Costa d'Avorio 2
NL - Olanda 2
PH - Filippine 2
BR - Brasile 1
CL - Cile 1
DK - Danimarca 1
ES - Italia 1
EU - Europa 1
HU - Ungheria 1
RO - Romania 1
SA - Arabia Saudita 1
VN - Vietnam 1
ZA - Sudafrica 1
Totale 1.258
Città #
Chandler 150
Houston 42
Ashburn 41
Dublin 31
San Mateo 25
Jacksonville 23
Ann Arbor 22
San Jose 19
Nanjing 18
Singapore 18
Dearborn 17
Wilmington 15
Princeton 12
Boston 11
Cattolica 11
New York 11
Beijing 10
Bremen 10
Milan 10
Woodbridge 10
Nürnberg 9
Brussels 8
Marseille 8
Albuquerque 7
Belize City 7
Moscow 7
Fairfield 6
Hangzhou 6
Munich 6
Andover 5
Lawrence 5
Los Angeles 5
Redwood City 5
Washington 5
Leawood 4
Nanchang 4
Rome 4
Brno 3
Chicago 3
Hebei 3
Izmir 3
Kunming 3
Las Vegas 3
Mountain View 3
Pune 3
Shenyang 3
Abidjan 2
Changsha 2
Crotone 2
Florence 2
Fremont 2
Kraków 2
Menlo Park 2
Paris 2
Remscheid 2
Saint Louis 2
San Diego 2
Shanghai 2
Zhengzhou 2
Amsterdam 1
Ardabil 1
Atlanta 1
Augusta 1
Baotou 1
Bari 1
Bern 1
Birmingham 1
Boardman 1
Brescia 1
Budapest 1
Buffalo 1
Changchun 1
Chengdu 1
Chiswick 1
Columbus 1
Duncan 1
Fondi 1
Forest City 1
Fuzhou 1
Guangzhou 1
Helsinki 1
Istanbul 1
Jiaxing 1
Jinan 1
Jinhua 1
Johannesburg 1
Kemerovo 1
Kish 1
La Spezia 1
La Trinidad 1
Lanzhou 1
London 1
Madrid 1
Manila 1
Marcon 1
Mcallen 1
Nave 1
New Delhi 1
Phoenix 1
Phoenixville 1
Totale 701
Nome #
Pros-IT CNR: an Italian prostate cancer monitoring project 206
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 167
Concurrent and adjuvant temozolomide-based chemoradiotherapy schedules for glioblastoma. Hypotheses based on two prospective phase II trials 125
Intensified adjuvant treatment of prostate carcinoma: feasibility analysis of a phase I/II trial 97
Disease-specific and general health-related quality of life in newly diagnosed prostate cancer patients: The Pros-IT CNR study 96
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 82
Standardized data collection to build prediction models in oncology: A prototype for rectal cancer 74
Radiotherapy in men with prostate cancer: indications, evolutions and integrated approaches 70
Predictive Factors of Late-onset Rectal Mucosal Changes After Radiotherapy of Prostate Cancer 61
PRODIGE: PRediction models in prOstate cancer for personalized meDIcine challenGE 54
Tailored postoperative treatment of prostate cancer: final results of a phase I/II trial 51
Radiotherapy of prostate cancer: Impact of treatment characteristics on the incidence of second tumors 44
Radiation therapy for prostate cancer: What's the best in 2021 42
Radiotherapy plus GnRH analogue versus high dose bicalutamide: A case control study 40
BIT-ART: Multicentric comparison of HDR-brachytherapy, intensity-modulated radiotherapy and tomotherapy for advanced radiotherapy in prostate cancer 36
Simultaneous integrated radiotherapy boost to the dominant intraprostatic lesion: Final results of a phase I/II trial 31
Radiotherapy of prostate carcinoma: A comparison of the predictive role of EAU versus NCCN risk stratification systems 30
Magnetic resonance guided SBRT reirradiation in locally recurrent prostate cancer: a multicentric retrospective analysis 2
Totale 1.308
Categoria #
all - tutte 5.043
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.043


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020202 24 3 10 7 21 19 13 6 21 6 51 21
2020/2021158 9 11 23 22 41 12 6 4 10 4 13 3
2021/2022156 11 8 4 8 12 8 5 24 9 11 32 24
2022/2023387 49 57 36 68 20 50 13 33 46 0 12 3
2023/2024173 10 49 7 13 6 29 7 7 5 6 16 18
2024/20257 7 0 0 0 0 0 0 0 0 0 0 0
Totale 1.308